Skip to main content

Table 7 TAHV is antigenically distinct from LACV and JCV by cross neutralizing antibody assay

From: Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys

Immunizing virusa   Serum neutralizing antibody titer against indicated virusb
  Monkey # LACV/78/NC-cl JCV/61/CO-cl TAHV/58/CZ-cl
LACV/78/NC-cl DB70 2077 <10 383
  DB8N 222 <10 <10
  CK74 2782 <10 80
  CL2G 326 <10 <10
  DBCZ 4728 <10 169
  CL6E 3719 <10 <10
  DB0H 364 <10 <10
  DA9F 1374 <10 82
  GMTc: 1177 <10 36
JCV/61/CO-cl A5E054 77 457 <10
  A5E060 2825 352 282
  A5E068 106 221 50
  A5E069 85 712 168
  A5E070 192 662 27
  A5E073 140 256 49
  A5E077 243 685 106
  DBXG 107 407 163
  GMT: 185 431 69
TAHV/58/CZ-cl DBPN 92 14 1698
  DBM6 58 <10 494
  A5E006 15 <10 360
  DBXJ 339 31 3195
  A5E036 113 <10 316
  L27 15 <10 215
  DC11 151 <10 1613
  GMT: 68 11 725
  1. a Monkeys were immunized subcutaneously with 5 log10 PFU of indicated virus and serum was collected on day 28.
  2. b Reciprocal PRNT60 assayed against indicated virus. Lower limit of detection is 10.
  3. b Geometric mean titer. For the purpose of calculation, a value of 9 was assigned to monkeys with titers less than 10.